California State Teachers Retirement System (CalSTRS)
RPRX icon

California State Teachers Retirement System (CalSTRS)’s Royalty Pharma RPRX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.2M Sell
699,205
-59,837
-8% -$3.11M 0.04% 363
2026
Q1 		$36.4M Sell
759,042
-22,477
-3% -$984K 0.04% 350
2025
Q4 		$30.2M Buy
781,519
+74,787
+11% +$2.85M 0.03% 422
2025
Q3 		$24.9M Buy
706,732
+40,324
+6% +$1.46M 0.03% 459
2025
Q2 		$24M Sell
666,408
-199,998
-23% -$6.63M 0.03% 465
2025
Q1 		$27M Sell
866,406
-9,862
-1% -$313K 0.03% 414
2024
Q4 		$22.4M Buy
876,268
+104,338
+14% +$2.77M 0.03% 478
2024
Q3 		$21.8M Buy
771,930
+40,490
+6% +$1.12M 0.03% 491
2024
Q2 		$19.3M Buy
731,440
+82,385
+13% +$2.28M 0.02% 500
2024
Q1 		$19.7M Buy
649,055
+13,533
+2% +$399K 0.02% 502
2023
Q4 		$17.9M Buy
635,522
+40,111
+7% +$1.1M 0.02% 518
2023
Q3 		$16.2M Sell
595,411
-10,881
-2% -$323K 0.02% 519
2023
Q2 		$18.6M Buy
606,292
+13,861
+2% +$469K 0.03% 494
2023
Q1 		$21.3M Sell
592,431
-2,686
-0.5% -$99.6K 0.03% 459
2022
Q4 		$23.5M Buy
595,117
+11,066
+2% +$462K 0.04% 423
2022
Q3 		$23.5M Sell
584,051
-4,704
-0.8% -$201K 0.04% 399
2022
Q2 		$24.8M Buy
588,755
+22,280
+4% +$913K 0.04% 403
2022
Q1 		$22.1M Sell
566,475
-30,394
-5% -$1.19M 0.03% 500
2021
Q4 		$23.8M Buy
596,869
+159,681
+37% +$6.2M 0.03% 508
2021
Q3 		$15.8M Sell
437,188
-134,196
-23% -$5.22M 0.02% 620
2021
Q2 		$23.4M Sell
571,384
-2,876
-0.5% -$122K 0.03% 510
2021
Q1 		$25M Buy
574,260
+376,887
+191% +$17.9M 0.03% 478
2020
Q4 		$9.88M Buy
197,373
+49,542
+34% +$2.1M 0.01% 768
2020
Q3 		$6.22M Buy
+147,831
New +$6.34M 0.01% 861

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s RPRX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Royalty Pharma (RPRX) stake by 7.9% in Q2 2026, selling an estimated $3.11M and leaving 699,205 shares worth $39.2M. The position accounts for 0.04% of the portfolio, ranked #363.

California State Teachers Retirement System (CalSTRS) first reported a position in RPRX in Q3 2020 and has held it in 24 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 699,205 shares of Royalty Pharma worth $39.2M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 59,837 Royalty Pharma shares in Q2 2026, an estimated $3.11M.
  • Royalty Pharma made up 0.04% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #363 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Royalty Pharma in Q3 2020 and has held it in 24 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.